Suppr超能文献

60岁以上老年人骨肉瘤:日本肌肉骨骼肿瘤学组的多中心研究。

Osteosarcoma in the elderly over 60 years: a multicenter study by the Japanese Musculoskeletal Oncology Group.

作者信息

Nishida Yoshihiro, Isu Kazuo, Ueda Takafumi, Nishimoto Yutaka, Tsuchiya Hiroyuki, Wada Takuro, Sato Keiji, Tsukushi Satoshi, Sugiura Hideshi

机构信息

Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

J Surg Oncol. 2009 Jul 1;100(1):48-54. doi: 10.1002/jso.21287.

Abstract

BACKGROUND

Few studies have described the characteristics and prognostic factors of osteosarcoma patients aged over 60 years.

METHODS

The Japanese Musculoskeletal Oncology Group (JMOG) carried out a retrospective review of patients over the age of 60 years with osteosarcoma.

RESULTS

Only 12 patients had secondary osteosarcoma, with none associated with Paget's disease. The primary disease sites were the extremities in 63% and trunk in 33%. The overall survival was 42.8% and disease-free survival was 40.8% at 5 years in the high grade group. An univariate analysis indicated that significant poor prognostic factors for overall survival were axial location, lung metastasis at initial presentation, and absence of surgical treatment. Multivariate analysis revealed that a significant poor prognostic factor for overall survival was the absence of surgical treatment. Secondary osteosarcoma did not lower the overall or the disease-free survival in any group.

CONCLUSIONS

The current study indicates that the number of osteosarcoma patients over 60 years is increasing. The number of cases with secondary osteosarcoma over 60 years is relatively small in Japan, with no patients having osteosarcomas related to Paget's disease. Although there is a predilection for axial localization, surgical treatment has a significant impact on patient's prognosis.

摘要

背景

很少有研究描述60岁以上骨肉瘤患者的特征和预后因素。

方法

日本肌肉骨骼肿瘤学组(JMOG)对60岁以上的骨肉瘤患者进行了回顾性研究。

结果

仅12例患者为继发性骨肉瘤,均与佩吉特病无关。原发疾病部位四肢占63%,躯干占33%。高级别组5年总生存率为42.8%,无病生存率为40.8%。单因素分析表明,总生存的显著不良预后因素为轴向位置、初次就诊时肺转移和未接受手术治疗。多因素分析显示,总生存的显著不良预后因素为未接受手术治疗。继发性骨肉瘤在任何组中均未降低总生存率或无病生存率。

结论

当前研究表明,60岁以上骨肉瘤患者数量正在增加。在日本,60岁以上继发性骨肉瘤病例数相对较少,没有患者患有与佩吉特病相关的骨肉瘤。尽管存在轴向定位倾向,但手术治疗对患者预后有显著影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验